Neonatal Sepsis
88
2
5
51
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Research Maturity
51 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.1%
1 terminated out of 88 trials
98.1%
+11.6% vs benchmark
17%
15 trials in Phase 3/4
14%
7 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (88)
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI
Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns
Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis
Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis
Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age
Use of Probiotics to Reduce Infections, Death and ESBL Colonisation
Smart Discharges for Mom & Baby
Azithromycin-Prevention in Labor Use Study (A-PLUS)
Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns
Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis
Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Uganda and Zimbabwe
Neonatal Sepsis and GBS Carriage Study
Clinical Impact of an Antibiotic Stewardship Program in a Neonatal Intensive Care Unit
Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock
Parental Participation on the Neonatal Ward - the neoPARTNER Study
Umbilical Cord Care in Term Neonates: The Role of Wondaleaf Adhesive Pouch (WLAP)
Clinical Value of Metagenomic Sequencing in Neonatal Sepsis
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis